New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription
出版年份 2019 全文链接
标题
New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription
作者
关键词
-
出版物
NUCLEIC ACIDS RESEARCH
Volume 47, Issue 20, Pages 10529-10542
出版商
Oxford University Press (OUP)
发表日期
2019-09-29
DOI
10.1093/nar/gkz835
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Recent Progress of Targeted G-Quadruplex-Preferred Ligands Toward Cancer Therapy
- (2019) Sefan Asamitsu et al. MOLECULES
- Characterization of Triple-Negative Breast Cancer Preclinical Models Provides Functional Evidence of Metastatic Progression
- (2019) Juan J. Arroyo-Crespo et al. INTERNATIONAL JOURNAL OF CANCER
- Advances in Targeted Therapies for Triple-Negative Breast Cancer
- (2019) Kelly E. McCann et al. DRUGS
- Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
- (2018) Alice Lee et al. CANCER TREATMENT REVIEWS
- Quinoxaline: An insight into the recent pharmacological advances
- (2018) Sana Tariq et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a New Four-Leaf Clover-Like Ligand as a Potent c-MYC Transcription Inhibitor Specifically Targeting the Promoter G-Quadruplex
- (2018) Ming-Hao Hu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Metastatic and triple-negative breast cancer: challenges and treatment options
- (2018) Sumayah Al-Mahmood et al. Drug Delivery and Translational Research
- Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going
- (2018) Claudia Omarini et al. Cancer Management and Research
- Ligand design to acquire specificity to intended G-quadruplex structures
- (2018) Sefan Asamitsu et al. CHEMISTRY-A EUROPEAN JOURNAL
- Emerging roles of Myc in stem cell biology and novel tumor therapies
- (2018) Go J. Yoshida JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers
- (2018) Edina Wang et al. ONCOGENE
- Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex
- (2018) David R. Calabrese et al. Nature Communications
- New Disubstituted Quindoline Derivatives Inhibiting Burkitt’s Lymphoma Cell Proliferation by Impeding c-MYC Transcription
- (2017) Hui-Yun Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel 11-Triazole Substituted Benzofuro[3,2-b]quinolone Derivatives as c-myc G-Quadruplex Specific Stabilizers via Click Chemistry
- (2017) De-Ying Zeng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Noninvasive89Zr-Transferrin PET Shows Improved Tumor Targeting Compared with18F-FDG PET in MYC-Overexpressing Human Triple-Negative Breast Cancer
- (2017) Kelly E. Henry et al. JOURNAL OF NUCLEAR MEDICINE
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression
- (2015) Kenneth M. Felsenstein et al. ACS Chemical Biology
- Interactions between Myc and MondoA transcription factors in metabolism and tumourigenesis
- (2015) Blake R Wilde et al. BRITISH JOURNAL OF CANCER
- Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP
- (2015) Liangliang Shen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma
- (2014) John C Castle et al. BMC GENOMICS
- Discovery of a new fluorescent light-up probe specific to parallel G-quadruplexes
- (2014) Shuo-Bin Chen et al. CHEMICAL COMMUNICATIONS
- HRASis silenced by two neighboring G-quadruplexes and activated by MAZ, a zinc-finger transcription factor with DNA unfolding property
- (2014) Susanna Cogoi et al. NUCLEIC ACIDS RESEARCH
- Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer
- (2012) James S. Duncan et al. CELL
- MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition
- (2012) Dai Horiuchi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Anticancer Activity and Cellular Repression of c-MYC by the G-Quadruplex-Stabilizing 11-Piperazinylquindoline Is Not Dependent on Direct Targeting of the G-Quadruplex in the c-MYC Promoter
- (2012) Peda V. L. Boddupally et al. JOURNAL OF MEDICINAL CHEMISTRY
- Crystal structure of a c-kit promoter quadruplex reveals the structural role of metal ions and water molecules in maintaining loop conformation
- (2012) D. Wei et al. NUCLEIC ACIDS RESEARCH
- 18F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
- (2011) N. Palaskas et al. CANCER RESEARCH
- Demonstration that Drug-targeted Down-regulation of MYC in Non-Hodgkins Lymphoma Is Directly Mediated through the Promoter G-quadruplex
- (2011) Robert V. Brown et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Solution Structure of a 2:1 Quindoline–c-MYC G-Quadruplex: Insights into G-Quadruplex-Interactive Small Molecule Drug Design
- (2011) Jixun Dai et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Triple-Negative Breast Cancer
- (2010) Steven J. Isakoff CANCER JOURNAL
- miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc
- (2010) Zhe Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evidence of the formation of G-quadruplex structures in the promoter region of the human vascular endothelial growth factor gene
- (2010) D. Sun et al. NUCLEIC ACIDS RESEARCH
- 9-N-Substituted berberine derivatives: Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc
- (2008) Yan Ma et al. BIOORGANIC & MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More